Consumer marketers sweat over congressional change

M. A.
May 2007
Medical Marketing & Media;May2007, Vol. 42 Issue 5, p9
Trade Publication
The article reports on the results of a survey conducted by Dendrite Relationship Marketing Operations regarding consumer marketers in the U.S. According to the study, the concern among consumer traffickers over popular backlash is easing, but anxiety about the prospect of increased regulation is up. Furthermore, marketers worried more about measurement, physician backlash and the declining effectiveness of direct to consumer (DTC) drug advertising.


Related Articles

  • Timed-release. Vence, Deborah L. // Marketing News;9/1/2005, Vol. 39 Issue 14, p4 

    Presents the findings of an online survey by Harris Interactive Inc. on whether direct-to-consumer advertising for prescription drugs should or should not be banned in the U.S.

  • Survey: pols don't dent DTC credibility. Arnold, Matthew // Medical Marketing & Media;Aug2008, Vol. 43 Issue 8, p28 

    The article presents a survey concerning the credibility of direct-to-consumer (DTC) for drug advertisements in the U.S. The survey reveals that the fury over these advertisements has not dented their credibility with consumers. It found little to suggest hardening in attitudes toward drug...

  • Poll shows good reaction to new wave of DTC ads. Wilke, Michael // Advertising Age;9/21/1998, Vol. 69 Issue 38, p44 

    The article reports on a survey conducted by Market Measures Inc. which evaluates how consumers are responding to television advertisements for prescription drugs. One major concern of the U.S. Food and Drug Administration is whether direct-to-consumer advertisements provide adequate safety...

  • DTC ads driving fewer to physicians, says survey. Arnold, Matthew // Medical Marketing & Media;Aug2009, Vol. 44 Issue 8, p26 

    The article features the results of the annual Consumer Reaction to direct-to-consumer (DTC) Advertising of Prescription Drugs survey conducted by Rodale Inc. in the U.S. Findings reveal that consumers do not often seek information about prescription medication or talk to doctors about...

  • DTC is dead/long live DTC. Chase, James // Medical Marketing & Media;Apr2011, Vol. 46 Issue 4, p6 

    An introduction to the journal is presented in which the author discusses the challenges in direct-to-consumer (DTC) drug marketing in the U.S.

  • Should we back DTC in Europe? Pavlou, Fedra // Pharmaceutical Technology Europe;Jan2011, Vol. 23 Issue 1, p6 

    An introduction to the journal is presented in which the editor discusses an article by Nathan Jessop on direct to consumer (DTC) advertising in Europe.

  • TVB study: DTC disclosures lend credibility to drug ads. Goetzl, David // Advertising Age;6/5/2000, Vol. 71 Issue 24, p6 

    This article presents the results of a market survey of U.S. adults by the Television Bureau of Advertising on direct-to-consumer (DTC) advertising for drugs. Majority of respondents find DTC drug ads trustworthy. Health-oriented ads led the way in consumer perception of trustworthiness. The...

  • Alcon Labs uses brains to test ad effectiveness. Chase, James // Medical Marketing & Media;Apr2009, Vol. 44 Issue 4, p28 

    The article reports the Alcon Laboratories Inc.'s measure of direct-to-consumer (DTC) advertising campaign effectiveness on the audience in the U.S. It notes that Alcon drew NeuroFocus to test its effectiveness by directly measuring signals from brains of the viewers. NeuroFocus recommends the...

  • ResearchWatch. Smith, Brian // Journal of Medical Marketing;Jan2009, Vol. 9 Issue 1, p77 

    The article discusses various reports published within the issue, including one which examines the fair balance in direct-to-consumer (DTC) pharmaceutical advertising, one which demonstrates the role of DTC advertising in constructing the social reality of diseases and medicine, and one on the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics